AVAtalk Technologies Inc.

What AVAtalk Technologies Inc. does

AVAtalk Technologies Inc. (doing business as AVAtalk Health Inc.) is a Montreal-based digital health company founded in 2022 that builds a browser-based platform for delivering Avatar therapy, an evidence-based psychotherapy originally developed in research settings for individuals experiencing distressing voices and intrusive thoughts. The platform comprises a Patient Web App accessible from any standard browser and a separate Clinician Portal that provides live avatar control, session records, and outcome tracking, supported by an AVAtalk Data Portal for administrative oversight. Underlying technical components include real-time voice transformation, avatar customization tools, and clinical-grade data security with encrypted transport and least-privilege access, all designed to enable single-clinician, single-room therapy delivery without specialized VR hardware.

The company operates a B2B2C subscription model, selling exclusively to enterprise buyers—primarily public psychiatric services, mental health trusts, specialist private clinics, and academic research groups—with patients accessing the platform indirectly through their treating clinicians. Pricing is quote-based and not publicly disclosed. Its go-to-market combines direct enterprise field sales to clinical services with a community-led research-collaboration motion supplying platform access and training to academic groups running randomized trials across indications including schizophrenia, OCD, PTSD, eating disorders, and depression. The company is led by co-founders Dr. Gail Myhr (Associate Professor of Psychiatry at McGill University, CSO) and Dr. Mohamad Matout (Clinical Assistant Professor at Stanford University), with Krista Payne (VP & GM at Evidera, Thermo Fisher Scientific) serving as Business Advisor. AVAtalk is anchored within the McGill University ecosystem through partnerships with the McGill University Health Centre, the Dobson Centre for Entrepreneurship, and the Healthy Brains, Healthy Lives initiative.

Name

AVAtalk Technologies Inc.

Legal name

AVAtalk Health Inc.

Website

https://avatalkapp.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

AVAtalk Health Inc. builds a browser-based digital platform that enables clinicians to deliver Avatar therapy—an evidence-based psychotherapy for distressing voices and intrusive thoughts—without specialized VR hardware, sold via B2B2C subscription to psychiatric services and academic research groups.

Ownership category

akta.pro rank

Product category

Digital Mental Health Platform

NAICS

Software Publishers (5132)

SIC

Services-Health Services (8000)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

Keywords

• Digital mental health
• Avatar therapy
• Clinical software platform
• Psychiatric care software
• Psychotherapy delivery platform

Headquarters

HQ city

Montreal

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Clinical Platform Subscription: Platform subscription model for psychiatric services and healthcare organizations, providing access to patient web app, clinician portal, onboarding, training, and ongoing technical and clinical support as an end-to-end clinical offering.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

AVAtalk develops and licenses a browser-based digital health platform that enables psychiatric services and mental health professionals to deliver Avatar therapy to patients experiencing distressing voices and intrusive thoughts, without specialized VR equipment. The platform consists of a Patient Web App and a Clinician Portal with a separate Data Portal, supporting avatar customization, real-time voice transformation, secure session management, and clinical outcome tracking. The offering is sold to healthcare organizations as an end-to-end clinical subscription that includes onboarding, training, and ongoing technical and clinical support.

Product overview

AVAtalk offers a single, unified browser-based platform for delivering Avatar therapy. The platform consists of two integrated interfaces: the Patient Web App, which allows patients to engage in guided avatar therapy sessions, and the Clinician Portal, which provides clinicians with live avatar control, real-time session monitoring, outcome tracking, and administrative oversight. The platform is designed for clinical deployment without requiring VR equipment, specialized hardware, or complex technical setups. The AVAtalk Data Portal provides additional administrative capabilities for service-level metrics and patient management.

Differentiator

Problem solved

Functional benefit

Products and services

• AVAtalk Platform A browser-based digital platform that enables therapists and psychiatric services to deliver Avatar therapy within their practice without specialized VR equipment, providing patient-facing and clinician-facing interfaces for conducting structured avatar therapy sessions.
• Patient Web App A web browser-based interface accessible from desktop, tablet, and phone that allows patients to engage in guided conversations with their personalized avatar in a secure, user-friendly environment without requiring VR hardware.
• Clinician Portal An integrated dashboard for clinicians to monitor patient progress, session history, and outcome metrics in real time; clinicians voice and guide avatars during therapy, maintaining full therapeutic oversight and controlling avatar expression and dialogue.
• AVAtalk Data Portal Admin dashboard with patient and user management capabilities for clinical oversight, service-level metrics tracking, session records, and outcome measure administration.

Quantifiable outcome

• Clinically significant improvements in voice-related distress and voice severity for participants with treatment-resistant voices
• +3 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered supporting, core and minor.

• McGill Dobson Centre for EntrepreneurshipsupportingStrategic or Co-development PartnerDobson Centre for Entrepreneurship at McGill University provides startup support and resources. AVAtalk appears to have emerged from or been supported by McGill University's entrepreneurship ecosystem, given the company's leadership ties to McGill.
• McGill University Health Centre (MUHC)coreStrategic or Co-development PartnerLeading academic medical center and research hospital in Montreal. Provides clinical research infrastructure and academic affiliation. Co-founder Dr. Gail Myhr is Associate Professor of Psychiatry at McGill University with connections to MUHC, enabling clinical research collaboration.
• Healthy Brains, Healthy LivessupportingStrategic or Co-development PartnerMcGill University initiative supporting brain health research. Provides funding and research support for innovative mental health interventions, supporting AVAtalk's clinical development and validation.
• CODE LiFE Ventilator ChallengeminorStrategic or Co-development PartnerMcGill-led innovation initiative supporting development of medical technologies. AVAtalk listed as a supported innovation under this healthcare innovation challenge framework.

Recent moves6 records

Expansion highlights4 records

Direct peers

• Ieso Digital Health: UK-based digital therapeutics platform delivering online CBT and behavioral therapy through a browser-based interface to NHS and private patients. Most direct peer: similar B2B2C model selling therapist-mediated digital mental health interventions to public health systems.
• Big Health: Digital therapeutics company with FDA-cleared products for insomnia (Sleepio) and anxiety (Daylight), sold via enterprise and payer channels. Closely comparable as a prescription digital therapeutics company targeting behavioral health with evidence-led, enterprise GTM.
• Meru Health: Digital mental health platform offering therapist-led, evidence-based programs for depression, anxiety, and burnout, distributed via employers and health plans. Comparable B2B2C digital therapeutics model with clinical-grade outcomes focus.
• Wysa: AI-driven mental health chatbot platform deployed in NHS trusts and employer benefits programs. Comparable digital behavioral health delivery model with enterprise (NHS/health plan) distribution focus.
• Akili Interactive: Digital therapeutics company with FDA-cleared prescription product (EndeavorRx) for ADHD and emerging products for depression/multiple sclerosis. Closely comparable as a software-based digital therapeutics company targeting psychiatric indications with regulatory validation.

Broad incumbents

• SilverCloud Health (Amwell): Digital mental health platform offering internet-delivered CBT programs across multiple indications, now part of Amwell. Comparable enterprise sales to health systems and payers but broader in scope and well-established in NHS deployments.
• Spring Health: Global employer and health plan mental health benefits platform combining provider matching, therapy, and digital tools. Comparable digital mental health distribution model but employer-led and far broader in scope.
• Headspace Health: Consumer and employer mental health platform offering meditation, therapy, and coaching (Headspace + Ginger). Comparable in digital mental health category but consumer-led with much larger scale and broader indication coverage.
• BetterHelp (Teladoc): Largest online therapy network within Teladoc Health, connecting consumers to licensed therapists via digital platform. Adjacent in digital mental health delivery but direct-to-consumer rather than enterprise clinical platform model.

Emerging players

• Limbic: UK digital mental health platform using AI to support self-referral and therapy matching within NHS IAPT pathways. Adjacent in digital mental health delivery but focuses on access/triage rather than novel therapy modalities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/avatalk-technologies-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AVAtalk Technologies Inc.